Pops-titration
Showing 1 - 25 of 858
Glaucoma, Intraocular Pressure Trial in Hat Yai (The pops-titration group, The slow-coagulation group)
Completed
- Glaucoma
- Intraocular Pressure
- The pops-titration group
- The slow-coagulation group
-
Hat Yai, Songkhla, ThailandOphthalmology Department, Prince of Songkla University
Mar 31, 2020
Obesity, Abdominal, Diabetes, Bariatric Surgery Candidate Trial (Cholestyramine Powder)
Not yet recruiting
- Obesity, Abdominal
- +2 more
- Cholestyramine Powder
- (no location specified)
Jul 28, 2023
Ventricular Tachycardia, Ventricular Arrythmia, Cardiomyopathies Trial in United States (AI-guided VA ablation)
Not yet recruiting
- Ventricular Tachycardia
- +2 more
- AI-guided VA ablation
-
Chicago, Illinois
- +3 more
Sep 18, 2023
Persistent Organic Pollutants and Type 2 Diabetes /Thyroid
Recruiting
- Type 2 Diabetes
- +2 more
-
Jinan, Shandong, ChinaXiaoling Guan
Feb 7, 2022
Adipose Tissue Pre and Post Bariatric Surgery
Active, not recruiting
- Obesity
- Bariatric surgery
- +7 more
-
Montreal, Quebec, CanadaInstitut de recherches cliniques de Montréal
Mar 22, 2022
Polybrominated Biphenyl Poisoning Trial in Atlanta (Orlistat, Placebo capsule)
Completed
- Polybrominated Biphenyl Poisoning
- Orlistat
- Placebo capsule
-
Atlanta, GeorgiaMichele Marcus
Sep 12, 2022
Contraception, Breastfeeding Trial in La Jolla (Progestin Only Contraceptive Pills)
Recruiting
- Contraception
- Breastfeeding
- Progestin Only Contraceptive Pills
-
La Jolla, CaliforniaUniversity of California, San Diego
Aug 4, 2022
Neonatal Jaundice, Microtia, Pregnancy Related Trial (Vivomixx®, Placebo)
Not yet recruiting
- Neonatal Jaundice
- +2 more
- Vivomixx®
- Placebo
- (no location specified)
Oct 17, 2023
Disease, Cardiovascular Diseases, Cancer Trial (Biomarkers of acrylamide, glycidol, POPs, PFAS)
Completed
- Disease
- +3 more
- Biomarkers of acrylamide, glycidol, POPs, PFAS
- (no location specified)
Jun 30, 2023
Hyperoxia Trial (FiO2 titration using electronic alert system)
Not yet recruiting
- Hyperoxia
- FiO2 titration using electronic alert system
- (no location specified)
Jun 20, 2023
Type 2 Diabetes Trial in New York, Charlottesville (Continuous Glucose Monitoring (CGM)-based titration algorithm implemented in
Not yet recruiting
- Type 2 Diabetes
- Continuous Glucose Monitoring (CGM)-based titration algorithm implemented in DiAs
-
New York, New York
- +1 more
Nov 2, 2023
Epilepsy Trial in Phoenix (Perampanel Oral Tablet)
Completed
- Epilepsy
- Perampanel Oral Tablet
-
Phoenix, ArizonaBanner University Medical Center Phoenix
May 16, 2022
Corneal Epithelial Degeneration Trial in Cypress (TTHX1114(NM141) Ophthalmic Solution)
Recruiting
- Corneal Epithelial Degeneration
- TTHX1114(NM141) Ophthalmic Solution
-
Cypress, CaliforniaTrefoil Clinical Site #132
Mar 3, 2023
Ards Trial in Denizli (No drugs or biologial agents were used in our trial)
Completed
- Ards
- No drugs or biologial agents were used in our trial
-
Denizli, TurkeyPamukkale University
Aug 8, 2023
Sleep Apnea Trial in Jeddah (Continuous Positive Airway Pressure (CPAP), High Flow Nasal Cannula (HFNC))
Recruiting
- Sleep Apnea
- Continuous Positive Airway Pressure (CPAP)
- High Flow Nasal Cannula (HFNC)
-
Jeddah, Western, Saudi ArabiaKing Abdulaziz University Hospital
Jul 24, 2022
CD20-positive Non-Hodgkin Lymphoma Trial in China (EX103 injection)
Recruiting
- CD20-positive Non-Hodgkin Lymphoma
- EX103 injection
-
Zhengzhou, Henan, China
- +3 more
Aug 28, 2023
Heart Failure Trial in Palo Alto (Audit and Feedback Emails, Patient Specific Targets, Educational Resources)
Not yet recruiting
- Heart Failure
- Audit and Feedback Emails
- +2 more
-
Palo Alto, CaliforniaPalo Alto Veteran's Affairs Hospital
Oct 24, 2023
(GDMT) Optimization and Adherence Longitudinal Study for Heart
Not yet recruiting
- Heart Failure
-
Durham, North Carolina
- +3 more
Jun 7, 2023
Esophagus Cancer, Bladder Cancer, Liver Cancer Trial (Intravenous injection of P-IL-2, P-IL-2 plus Anti-PD-1 Monoclonal
Not yet recruiting
- Esophagus Cancer
- +4 more
- Intravenous injection of P-IL-2
- P-IL-2 plus Anti-PD-1 Monoclonal Antibody
- (no location specified)
Apr 24, 2023
Positive End-expiratory Pressure, Hemodynamic Variable, Postoperative Atelectasis Trial in Tanta (Positive end-expiratory
Recruiting
- Positive End-expiratory Pressure
- +3 more
- Positive end-expiratory pressure 5 (PEEP 5)
- Individualized positive end-expiratory pressure (PEEPIND)
-
Tanta, El-Gharbia, EgyptTanta University
Nov 5, 2023